Clinical outcome of breast cancer patients with liver metastases alone in the anthracycline-taxane era: a retrospective analysis of two prospective, randomised metastatic breast cancer trials.

Atalay G., Biganzoli L., Renard F., Paridaens R., Cufer T., Coleman R., ...Daha Fazla

European journal of cancer (Oxford, England : 1990), cilt.39, ss.2439-49, 2003 (SCI-Expanded, Scopus)

• Yayın Türü: Makale / Tam Makale
• Cilt numarası: 39
• Basım Tarihi: 2003
• Doi Numarası: 10.1016/s0959-8049(03)00601-4
• Dergi Adı: European journal of cancer (Oxford, England : 1990)
• Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
• Sayfa Sayıları: ss.2439-49
• Anahtar Kelimeler: breast cancer, liver metastases, HIGH-DOSE CHEMOTHERAPY, LONG-TERM SURVIVAL, PROGNOSTIC-FACTORS, COMBINATION CHEMOTHERAPY, EUROPEAN ORGANIZATION, FOLLOW-UP, DOXORUBICIN, DOCETAXEL, ESTROGEN, THERAPY
• Acıbadem Mehmet Ali Aydınlar Üniversitesi Adresli: Hayır